Annuobaide's Series A Round

Annuobaide raised a round of funding on April 19, 2018. Investors include ShareLink Capital.

Annuobaide (安诺柏德) is engaged in the research & development of cancer immunotherapy and CAR T technology, including an antibody screening platform, a clinical lentivirus production platform, an…

Articles about Annuobaide's Series A Round: